Dr. Waqaas Al-Siddiq DBA, the founder of Biotricity, is a leader in healthcare innovation. Recognized as a serial entrepreneur, former investment advisor, expert in corporate strategy, and innovative technologist, Waqaas is vested in the potential that IoT-connected technology, enhanced with AI, could bring to healthcare. He’s often a guest speaker at major conferences, podcasts, and media outlets, discussing topics such as AI, implementation of new technologies into healthcare, and development of medical devices for underserved communities. Waqaas is distinguished for his state-of-the-art designs in digital, analog, embedded, and micro-electro-mechanical products and has held several high-level design positions at IBM, AMD, and Intel. Waqaas has vast experience leading various groups through his board experience with several innovative companies in the healthcare and AI industries, as well as his executive roles within start-ups, mid-sized companies, and non-profits. Waqaas raised over $150M as an entrepreneur and successfully commercialized 15+ products in multiple countries.
When it comes to heart health, time is of the essence. ECGs are considered the most reliable tools, but only if they are continuous and long-term in nature. Continuous Heart Rhythm Monitoring is simply the only solution for prevention and/or management for the number one global health issue.
By following the patient at each stage of its disease progression, from diagnosis to disease management, and integrating a variety of technologies, digital health provides deeper insights and help for care management.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Telehealth utilization has dropped as the pandemic emergency has waned. For telehealth utilization to meet the higher expectations set during the pandemic, the technology must be wielded for more than just episodic or urgent care.
The traditional fee-for-service arrangements have caused misaligned incentives across the board for patients, physicians, and payers – and proved a huge obstacle to improving care. Recognizing this gap, CMS began to facilitate a shift towards outcome-based care by focusing on outpatient monitoring and disease management. This has led to progress in adopting new reimbursement models.